Form 4: OPKO Health Director Yu Alice Lin-Tsing Reports Stock Option Grant
SEC Form 4 Filing
Director Yu Alice Lin-Tsing reports acquisition of stock options in OPKO Health, Inc.
Summary
- On March 28, 2024, Yu Alice Lin-Tsing, a director of OPKO Health, Inc., reported a transaction involving derivative securities.
- Specifically, Ms. Yu acquired stock options, representing the right to buy 30,000 shares of OPKO Health's common stock.
- The exercise price of these options is $1.2.
- The options become exercisable on March 28, 2025, and expire on March 27, 2034.
- Following the reported transaction, Ms. Yu directly owns 30,000 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing about stock option grants to a director. While option grants can be seen as a positive incentive, the filing itself is simply a disclosure.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of transaction: acquisition of stock options. |
| 03/28/2025 | Date the stock options become exercisable. |
| 03/27/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.